While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...
Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...
Flu cases are continunig to soar across Northern Ireland ...
The company's worst days might be behind it.
In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...
The U.S. Food and Drug Administration (FDA) recently announced that it may ease the "serious side effects" warning labels on ...
GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...